Aspergillus fumigatus in cystic fibrosis: An update on immune interactions and molecular diagnostics in allergic bronchopulmonary aspergillosis

Allergy
A CarsinJ Vitte

Abstract

A wide spectrum of pathological conditions may result from the interaction of Aspergillus fumigatus and the immune system of its human host. Allergic bronchopulmonary aspergillosis is one of the most severe A. fumigatus-related diseases due to possible evolution toward pleuropulmonary fibrosis and respiratory failure. Allergic bronchopulmonary aspergillosis occurs almost exclusively in cystic fibrosis or asthmatic patients. An estimated 8%-10% of patients with cystic fibrosis experience this condition. The diagnosis of allergic bronchopulmonary aspergillosis relies on criteria first established in 1977. Progress in the understanding of host-pathogen interactions in A. fumigatus and patients with cystic fibrosis and the ongoing validation of novel laboratory tools concur to update and improve the diagnosis of allergic bronchopulmonary aspergillosis.

References

Oct 1, 1988·Medical Decision Making : an International Journal of the Society for Medical Decision Making·J A KoziolR Taetle
Dec 1, 1994·American Journal of Respiratory and Critical Care Medicine·J M el-DahrP W Heymann
Sep 1, 1997·Methods : a Companion to Methods in Enzymology·R E Esch
Mar 3, 1998·International Archives of Allergy and Immunology·R Crameri
Oct 16, 1999·The Journal of Allergy and Clinical Immunology·Y AronB S Polla
Jun 10, 2000·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·V P KurupR Crameri
Sep 17, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David A StevensUNKNOWN Participants in the Cystic Fibrosis Foundation Consensus Conference
Oct 2, 2003·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·A MariB Simon-Nobbe
May 5, 2005·The Journal of Infectious Diseases·Jacques BrouardAnnick Clement
Sep 1, 2005·Apoptosis : an International Journal on Programmed Cell Death·S BhattacharyaL R Johnson
Mar 1, 2006·Clinical and Molecular Allergy : CMA·Alan P KnutsenManoj R Warrier
Jul 25, 2006·Clinical and Molecular Allergy : CMA·Viswanath P KurupNaveen K Bansal
Jul 21, 2009·Microbes and Infection·Viviane Balloy, Michel Chignard
Oct 6, 2009·European Journal of Dermatology : EJD·Hagen OttJens Malte Baron
Feb 1, 2011·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Carey C LindenEdward M Zoratti
Apr 27, 2011·Allergy·I Tillie-LeblondB Wallaert
Sep 2, 2011·European Respiratory Review : an Official Journal of the European Respiratory Society·M KoushaA O Soubani
Jan 31, 2012·The Journal of Allergy and Clinical Immunology·Alan P KnutsenAndrew J Wardlaw
Jul 27, 2012·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·María PedrosaSantiago Quirce
Aug 29, 2012·Diagnostic Microbiology and Infectious Disease·Albert W van Toorenenbergen
Sep 7, 2012·Cold Spring Harbor Perspectives in Medicine·Silvia M KredaMary Callaghan Rose
Jan 22, 2013·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·C G BaxterM D Richardson
Mar 15, 2013·Journal of Innate Immunity·Yun ZhouGuoshun Wang
Jul 31, 2013·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·R AgarwalUNKNOWN ABPA complicating asthma ISHAM working group
Oct 5, 2013·The World Allergy Organization Journal·Giorgio Walter CanonicaUNKNOWN WAO-ARIA-GA2LEN Task Force: Katrina Allen, Riccardo Asero, Barbara Bohle, Linda Cox, Frederic de Blay, Motohiro Ebisawa, Ren
Nov 30, 2013·Allergy·R CrameriC Huitema
Dec 18, 2013·The Pediatric Infectious Disease Journal·Judith FillauxJean-François Magnaval
Jan 1, 2014·Infection and Immunity·Lauren M LillyChad Steele
Apr 5, 2014·The Journal of Allergy and Clinical Immunology·Robert G Hamilton
May 8, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jose F Camargo, Shahid Husain

❮ Previous
Next ❯

Citations

Feb 26, 2019·Experimental Dermatology·Qingqing JiaoMarcus Maurer
Feb 16, 2019·Frontiers in Cellular and Infection Microbiology·Raphaël P PiarrouxStéphane Ranque
May 1, 2021·International Journal of Molecular Sciences·Martin VossAnne Dudeck
Jan 15, 2020·Archivos de bronconeumología·Wei TangJuntao Feng

❮ Previous
Next ❯

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.